FBXO45 and ovarian serous adenocarcinoma: FBXO45 was highly expressed in plasmacytoid ovarian cancer in the GSE36668 dataset of the GEO database by analyzing data from four normal ovaries and four patients with serous ovarian cancer (Figure 4C).